Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up) (AMP Up)
-
- STATUS
- Recruiting
-
- End date
- Jul 14, 2025
-
- participants needed
- 850
-
- sponsor
- Harvard School of Public Health (HSPH)
Summary
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.
Description
AMP Up aims to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition into adulthood. A group of uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.
The primary objectives of this study are:
- To identify infectious and non-infectious complications of HIV disease and toxicities resulting from long-term ART, including disease progression, immune dysfunction, viral resistance, end-organ disease, and mortality.
- To define the impact of HIV infection and ART on the long-term clinical outcomes of young adults, including:
- Metabolic abnormalities and risk factors for cardiovascular disease, including glucose and lipid metabolism, blood pressure, and body composition.
- Sexually transmitted infections (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, syphilis, human papillomavirus, genital warts and HSV) among males and females, and cervical HPV-associated pre-cancers and cancers and Mycoplasma genitalium and other vaginal microbiota among females.
- Reproductive health, fertility, and pregnancy outcomes including mother-to-child transmission of HIV.
- To define the impact of perinatal HIV infection, its concominant risk factors and ART on long-term neurocognitive and behavioral health outcomes, including:
- Mental health and neurocognitive functioning.
- Health care behaviors, including adherence to ART, participation in health care services, and transition to adult clinical care.
- Risk behaviors, including sexual behavior and substance use.
- Independent living skills, and vocational and education achievement necessary for successful transition to adult functioning and quality of life.
Details
| Condition | HIV/AIDS |
|---|---|
| Clinical Study Identifier | NCT02119702 |
| Sponsor | Harvard School of Public Health (HSPH) |
| Last Modified on | 7 October 2022 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer